ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623639; 2) Community: the network communities that were significantly associated with the response to NSC 623639; 3) Molecule: the relationships between components within communities and NSC 623639; 4) MDR: the compounds that were significantly associated with the NSC 623639.

NSC Compound Enrichment Correlation
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00286159651545682 0.84988787
NSC 651590 ANTINEOPLASTIC-651590 0.00286159651545682 0.78104969
NSC 657446 Thiazolo[2,3-b]thiazolium, 2,3-dihydro- 2-[(2-methoxyphenyl)methylene]- 5-(3-nitrophenyl)-3-oxo-, chloride 0.00286159651545682 0.76477891
NSC 680721 5H-1,4,8,11-Benzotetrathiacyclotridecin- 13,14-dicarbonitrile, 2,3,6,7,9,10-hexahydro- 0.00286159651545682 -0.22602089
NSC 708806 Null 0.00286159651545682 0.21426216
NSC 81052 Streptonigrin analog (MeO-N3) 0.00286159651545682 0.78697243
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.00293992674122322 0.40905013
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.00293992674122322 0.6526051
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.00293992674122322 0.40441558
NSC 208885 Null 0.00293992674122322 0.062594172
Total:136  Current:22    [First] [Prev] [Next] [Last]